Eli Lilly Expands Oncology Ambitions with Up to $2.3 Billion Ajax Therapeutics Acquisition
Eli Lilly has announced a major strategic move to strengthen its oncology portfolio through the acquisition of Ajax Therapeutics in a deal valued at...
India–New Zealand FTA Opens Zero-Duty Pharma Gateway, Boosting ‘Made in India’ Healthcare Exports
In a significant boost for India’s healthcare and pharmaceutical ecosystem, the newly signed India–New Zealand Free Trade Agreement (FTA) is set to create powerful...
Sun Pharma to Acquire Organon in Transformative $11.75 Billion Deal Focused on Women’s Health
Sun Pharma has announced a landmark definitive agreement to acquire Organon in an all-cash transaction valued at approximately $11.75 billion, marking one of the...
Novartis Receives European Commission Approval for Rhapsido®, the First Oral Targeted Therapy for Chronic Spontaneous Urticaria
Novartis has officially received European Commission (EC) approval for Rhapsido® (remibrutinib), marking a historic shift in the management of chronic spontaneous urticaria (CSU). Rhapsido...
A Global Pediatric Milestone: WHO Pre qualifies First Malaria Treatment for Newborns and Young Infants
In a landmark step for global child health, the World Health Organization (WHO) has prequalified the world’s first malaria treatment specifically designed for newborns...
AbbVie Moves Toward “Fast-Acting” Botox Alternative: FDA Requests Final Manufacturing Details for 24-Hour Frown Line Treatment
AbbVie is set to rewrite the timeline of aesthetic medicine, as it received the receipt of a Complete Response Letter (CRL) from the...
